🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
This will be a double-blind, randomized, placebo-controlled, parallel group...
Status
Completed
Location
University of Alabama
Start Date
2015-11
Trial ID
NCT02589236
Treatments Being Tested
The study is a Phase 2 Study to establish the safety and efficacy of a drug...
Status
Completed
Location
UAB Lung Health Center
Start Date
2017-03-16
Trial ID
NCT03085485
Treatments Being Tested
To evaluate the clinical mechanisms of action in lung and extrapulmonary sy...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02508207
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo- and tezacaftor/ivacaf...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2017-08-08
Trial ID
NCT03224351
The purpose of this study was to evaluate the safety and tolerability of iv...
Status
Completed
Location
University of Alabama Hospital
Start Date
2007-05
Trial ID
NCT00457821
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo-controlled, multicente...
Status
Completed
Location
University Medical Center, Utrecht, Department of Pulmonology and Tuberculosis
Start Date
2017-01-31
Trial ID
NCT03061331
The primary objective of the study was to evaluate the efficacy of lumacaft...
Status
Completed
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01807949
Treatments Being Tested
This study is designed to evaluate the effect of multiple doses of lumacaft...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01910415
Treatments Being Tested
To evaluate the safety and efficacy of treatment with VX-371 with and witho...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT02871778
Treatments Being Tested